Disease Prevention Journals
Disease prevention, understood as specific, population-based and individual-based interventions for primary and secondary (early detection) prevention, aiming to minimize the burden of diseases and associated risk factors. Primary prevention refers to actions aimed at avoiding the manifestation of a disease (this may include actions to improve
health through changing the impact of social and economic determinants on health; the provision of
information on behavioral and medical
health risks, alongside consultation and measures to decrease them at the personal and community level; nutritional and food supplementation; oral and dental hygiene education; and clinical preventive services such as immunization and
vaccination of children, adults and the elderly, as well as
vaccination or post-exposure prophylaxis for people exposed to a communicable disease). Secondary prevention deals with early detection when this improves the chances for positive
health outcomes (this comprises activities such as evidence-based
screening programs for early detection of diseases or for prevention of congenital malformations; and preventive drug therapies of proven effectiveness when administered at an early stage of the disease).
Health promotion is the process of empowering people to increase control over their
health and its determinants through
health literacy efforts and multisectoral action to increase healthy behaviors. This process includes activities for the community-at-large or for populations at increased risk of negative
health outcomes.
Health promotion usually addresses behavioral risk factors such as tobacco use, obesity, diet and physical inactivity, as well as the areas of mental health, injury prevention,
drug abuse control, alcohol control,
health behavior related to HIV, and sexual health.
High Impact List of Articles
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Role of indacaterol in the management of asthma and chronic obstructive pulmonary disease
Federico L Dente,Elena Bacci, Barbara Vagaggini, Pierluigi Paggiaro
Review Article: Clinical Investigation
-
Role of indacaterol in the management of asthma and chronic obstructive pulmonary disease
Federico L Dente,Elena Bacci, Barbara Vagaggini, Pierluigi Paggiaro
Review Article: Clinical Investigation
Relevant Topics in Clinical